MS Treatment Choice May Influence Depression Risk ...Middle East

Patients with MS who receive rituximab are 28% less likely to develop depression, compared with patients who receive interferons. Depression also may influence adherence to interferons. Medscape Medical News

Hence then, the article about ms treatment choice may influence depression risk was published today ( Friday 13/08/2021 - 11:30 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( MS Treatment Choice May Influence Depression Risk )

Also on site :

• 'The chances of you living 50 years are very small': Theoretical physicist explains why humanity likely won't survive to see all the forces unified
• Former U.S. Presidents, Entertainment, Sports and Media Leaders Convene in Rare Gathering to Celebrate Country’s 250th Anniversary
• The Strokes End Coachella Performance With Video Montage Condemning U.S. and Israeli Bombings in Iran and Gaza